Charnwood Discovery
Hassan Srour is a Senior Research Scientist at Charnwood Discovery since March 2020, focusing on the design and synthesis of new bioactive molecules within medicinal chemistry programs. Previously, Hassan Srour held a postdoctoral researcher position at the Université de Strasbourg from October 2016 to May 2019, developing innovative in vitro methods to assess the sensitizing potential of chemical substances, alongside synthesizing carbon-13 labeled sensitizing molecules. Earlier experience also includes postdoctoral research at the Laboratoire de Chimie Moléculaire et Thio-organique (ENSICAEN) from January 2014 to January 2016, where Hassan Srour synthesized and characterized fluorescent molecules derived from dibenzoanthracene and di-indolocarbazole. Hassan Srour commenced a research career as a doctoral candidate at the Institut des Sciences Chimiques de Rennes, completing a PhD in Chemistry at the Université de Rennes I in 2013, preceded by a Master’s degree in Molecular Chemistry from the same institution.
This person is not in any offices
Charnwood Discovery
Charnwood Discovery is a leading provider of drug discovery services, from standalone customized solutions through to fully integrated programs that enhance the experience and success of complex drug discovery. Founded in 1998 we have grown and expanded to offer multiple services across chemistry, bioscience and ADME / DMPK and are an established partner of choice for many biotech and pharmaceutical companies. Our client centric, flexible approach, combined with a commitment to innovation and excellence sees many clients return to us year on year to support their research programs. We add value across the drug discovery pipeline from target validation through to pre-clinical candidates. Whether you need a standalone or fully integrated solution our multidisciplinary teams work together to enable rapid problem solving and the best possible project outcomes.